↓ Skip to main content

Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell

Overview of attention for article published in BMC Complementary Medicine and Therapies, August 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
twitter
4 X users

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
61 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Berberine inhibits NLRP3 Inflammasome pathway in human triple-negative breast cancer MDA-MB-231 cell
Published in
BMC Complementary Medicine and Therapies, August 2019
DOI 10.1186/s12906-019-2615-4
Pubmed ID
Authors

Mingjiang Yao, Xiaodi Fan, Bo Yuan, Norio Takagi, Sai Liu, Xiao Han, Junguo Ren, Jianxun Liu

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 61 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 61 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 11%
Student > Doctoral Student 7 11%
Other 6 10%
Student > Bachelor 5 8%
Researcher 5 8%
Other 8 13%
Unknown 23 38%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 15 25%
Pharmacology, Toxicology and Pharmaceutical Science 7 11%
Medicine and Dentistry 4 7%
Agricultural and Biological Sciences 2 3%
Immunology and Microbiology 2 3%
Other 4 7%
Unknown 27 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 June 2022.
All research outputs
#2,628,422
of 23,342,092 outputs
Outputs from BMC Complementary Medicine and Therapies
#467
of 3,682 outputs
Outputs of similar age
#54,901
of 343,349 outputs
Outputs of similar age from BMC Complementary Medicine and Therapies
#6
of 102 outputs
Altmetric has tracked 23,342,092 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,682 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,349 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 102 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.